A new analysis from the Office of Inspector General found a similar net cost for drugs through vertically-integrated Part D plans compared to other plans. | A new analysis from the Office of Inspector General found a similar net cost for drugs through vertically-integrated Part D plans compared to other plans.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Fewer than a third of people with commercial coverage say that their plans represent a "trusted partner" in their health,…
Drug spending is rising sharply, with high-cost GLP-1 medications driving nearly half of the incr | How RxSense helped a health…
LAS VEGAS — As drug costs and spending continue to rise, the demand for solutions opens the door to closer collaboration between…
Despite steady demand for obesity medications, 49% of payers who do not currently cover GLP-1s for obesity would not do so at any…
The Federal Trade Commission may be winding down its ongoing insulin case against the three largest pharmacy benefit managers, as…
A group representing thousands of pharmacies has filed an antitrust suit against Prime Therapeutics, alleging that the company…
